Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$4.0 - $21.53 $1.51 Million - $8.11 Million
-376,838 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$13.94 - $24.12 $5.25 Million - $9.09 Million
376,838 New
376,838 $8.08 Million
Q3 2019

Nov 14, 2019

SELL
$13.89 - $23.16 $3.13 Million - $5.22 Million
-225,339 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$16.27 - $20.51 $3.67 Million - $4.62 Million
225,339 New
225,339 $4.37 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $250M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Crawford Lake Capital Management, LLC Portfolio

Follow Crawford Lake Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.